Jose Miguel Frade

Title: The Innovative Contributions of Jose Miguel Frade

Introduction

Jose Miguel Frade is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic and diagnostic applications. With a total of 2 patents, his work has the potential to impact various medical fields.

Latest Patents

Frade's latest patents include groundbreaking inventions related to antibodies targeting the chemokine receptor-2 (CCR2) and a specific monoclonal antibody for human growth hormone. The first patent focuses on antibodies that can bind to the monocyte chemoattractant protein 1 (MCP-1) receptor CCR2, acting as either an antagonist or agonist. These antibodies are valuable for in vitro and in vivo diagnostics, drug screening, and therapeutic applications. The second patent involves a monoclonal antibody that specifically binds to the 20 kDa variant of human growth hormone, allowing for accurate measurement and quantification in body fluids, particularly serum.

Career Highlights

Throughout his career, Jose Miguel Frade has worked with prominent organizations such as Pharmacia & Upjohn Ab and the Consejo Superior de Investigaciones Científicas. His experience in these institutions has contributed to his expertise in antibody development and biotechnology.

Collaborations

Frade has collaborated with notable colleagues, including Carlos Martinez Alonso and Jose Mario Garcia. These partnerships have likely enhanced his research and innovation efforts in the field.

Conclusion

Jose Miguel Frade's contributions to biotechnology through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical diagnostics and therapeutics.